Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.549
Filter
1.
Chest ; 165(5): e133-e136, 2024 May.
Article in English | MEDLINE | ID: mdl-38724151

ABSTRACT

We describe the case of a young 33-year-old woman that was referred to our clinic for evidence of migrant cavitary nodules at CT scan, dyspnea, and blood sputum. Her physical examination showed translucent and thin skin, evident venous vascular pattern, vermilion of the lip thin, micrognathia, thin nose, and occasional Raynaud phenomenon. We prescribed another CT scan that showed multiple pulmonary nodules in both lungs, some of which had evidence of cavitation. Because bronchoscopy was not diagnostic, we decided to perform surgical lung biopsy. At histologic examination, we found the presence of irregularly shaped, but mainly not dendritic, foci of ossification that often contained bone marrow and were embedded or surrounded by tendinous-like fibrous tissue. After incorporating data from the histologic examination, we decided to perform genetic counseling and genetic testing with the use of whole-exome sequencing. The genetic test revealed a heterozygous de novo missense mutation of COL3A1 gene, which encodes for type III collagen synthesis, and could cause vascular Ehlers-Danlos syndrome.


Subject(s)
Collagen Type III , Hemoptysis , Tomography, X-Ray Computed , Humans , Female , Adult , Hemoptysis/etiology , Hemoptysis/diagnosis , Collagen Type III/genetics , Ehlers-Danlos Syndrome/diagnosis , Ehlers-Danlos Syndrome/complications , Ehlers-Danlos Syndrome/genetics , Diagnosis, Differential , Mutation, Missense , Multiple Pulmonary Nodules/diagnosis , Multiple Pulmonary Nodules/diagnostic imaging , Lung/diagnostic imaging , Lung/pathology
2.
Rev Mal Respir ; 41(6): 446-450, 2024 Jun.
Article in French | MEDLINE | ID: mdl-38796385

ABSTRACT

Pulmonary actinomycosis is a rare infectious disease that can be difficult to diagnose due to nonspecific imaging abnormalities and to a need for repeated lung sampling by CT-guided biopsy or bronchoscopy. It may present with hemoptysis, which can occur with or without antibiotic therapy and bronchial artery embolization may be required. We report here a case of pulmonary actinomycosis with imaging by thoracic CT, digital subtraction angiography, and pathological specimens.


Subject(s)
Actinomycosis , Bronchial Arteries , Embolization, Therapeutic , Tomography, X-Ray Computed , Humans , Actinomycosis/diagnosis , Actinomycosis/diagnostic imaging , Embolization, Therapeutic/methods , Tomography, X-Ray Computed/methods , Bronchial Arteries/pathology , Bronchial Arteries/diagnostic imaging , Male , Hemoptysis/etiology , Hemoptysis/therapy , Hemoptysis/diagnosis , Middle Aged , Bronchoscopy/methods , Female , Angiography, Digital Subtraction/methods
4.
BMC Pulm Med ; 24(1): 203, 2024 Apr 24.
Article in English | MEDLINE | ID: mdl-38658883

ABSTRACT

BACKGROUND: Bronchial arterial embolization (BAE) has been accepted as an effective treatment for bronchiectasis-related hemoptysis. However, rare clinical trials compare different sizes of specific embolic agents. This study aims to evaluate whether different Embosphere microsphere sizes change the outcome of BAE. METHODS: A retrospective review was conducted on consecutive patients with bronchiectatic hemoptysis who were scheduled to undergo BAE treatment during a period from January 2018 to December 2022. The patients received BAE using microspheres of different sizes: group A patients were treated with 500-750 µm microspheres, and group B patients were treated with 700-900 µm microspheres. The cost of embolic microspheres (Chinese Yuan, CNY), duration of hospitalization, complications, and hemoptysis-free survival were compared between patients in group A and those in group B. A Cox proportional hazards regression model was used to identify predictors of recurrent hemoptysis. RESULTS: Median follow-up was 30.2 months (range, 20.3-56.5 months). The final analysis included a total of 112 patients (49-77 years of age; 45 men). The patients were divided into two groups: group A (N = 68), which received 500-750 µm Embosphere microspheres, and group B (N = 44), which received 700-900 µm Embosphere microspheres. Except for the cost of embolic microspheres(group A,5314.8 + 1301.5 CNY; group B, 3644.5 + 1192.3 CNY; p = 0.042), there were no statistically significant differences in duration of hospitalization (group A,7.2 + 1.4 days; group B, 8 + 2.4days; p = 0.550), hemoptysis-free survival (group A, 1-year, 2-year, 3-year, 85.9%, 75.8%, 62.9%; group B, 1-year, 2-year, 3-year, 88.4%, 81.2%,59.4%;P = 0.060), and complications(group A,26.5%; group B, 38.6%; p = 0.175) between the two groups. No major complications were observed. The multivariate analysis results revealed that the presence of cystic bronchiectasis (OR 1.61, 95% CI 1.12-2.83; P = 0.001) and systemic arterial-pulmonary shunts (SPSs) (OR 1.52, 95% CI 1.10-2.72; P = 0.028) were independent risk factors for recurrent bleeding. CONCLUSIONS: For the treatment of BAE in patients with bronchiectasis-related hemoptysis, 500-750 µm diameter Embosphere microspheres have a similar efficacy and safety profile compared to 700-900 µm diameter Embosphere microspheres, especially for those without SPSs or cystic bronchiectasis. Furthermore, the utilization of large-sized (700-900 µm) Embosphere microspheres is associated with the reduced cost of an embolic agent.


Subject(s)
Acrylic Resins , Bronchial Arteries , Bronchiectasis , Embolization, Therapeutic , Hemoptysis , Microspheres , Humans , Hemoptysis/therapy , Hemoptysis/etiology , Retrospective Studies , Male , Female , Embolization, Therapeutic/methods , Middle Aged , Aged , Bronchiectasis/complications , Bronchiectasis/therapy , Gelatin/administration & dosage , Gelatin/therapeutic use , Treatment Outcome , Particle Size
5.
BMC Pulm Med ; 24(1): 192, 2024 Apr 22.
Article in English | MEDLINE | ID: mdl-38644505

ABSTRACT

BACKGROUND: Stenosis and obliteration of the pulmonary vein can be developed by multiple diseases and might cause hemoptysis. Traditional therapy including surgical procedure and conservative treatments might be inappropriate choices to manage massive hemoptysis. CASE PRESENTATION: A 64-year-old man, diagnosed with advanced stage IVA lung squamous cell carcinoma, presented with dyspnea and recurrent, massive hemoptysis. An initial contrast-enhanced computed tomography revealed a giant tumor in the left lung hilus and occlusion of the left superior pulmonary vein. Despite immediate selective bronchial artery embolization and simultaneous embolization of an anomalous branch of the internal thoracic artery, the massive hemoptysis continued. Subsequently, embolization of the left superior pulmonary artery was performed, achieving functional pulmonary lobectomy, which successfully treated the hemoptysis without relapse during a six-month follow-up. The patient continues to undergo cancer therapy and remains stable. CONCLUSIONS: This case successfully managed massive hemoptysis associated with lung cancer invasion into the pulmonary vein through functional pulmonary lobectomy via embolization of the corresponding pulmonary artery.


Subject(s)
Carcinoma, Squamous Cell , Embolization, Therapeutic , Hemoptysis , Lung Neoplasms , Pulmonary Artery , Tomography, X-Ray Computed , Humans , Hemoptysis/therapy , Hemoptysis/etiology , Male , Middle Aged , Embolization, Therapeutic/methods , Lung Neoplasms/complications , Lung Neoplasms/therapy , Pulmonary Artery/diagnostic imaging , Carcinoma, Squamous Cell/complications , Carcinoma, Squamous Cell/therapy , Pulmonary Veins/abnormalities , Pulmonary Veins/diagnostic imaging , Pneumonectomy
6.
Article in Chinese | MEDLINE | ID: mdl-38677989

ABSTRACT

Objective: To investigate the clinical characteristics and prognosis of silicosis complicated with cavity-pulmonary tuberculosis. Methods: The clinical data of 63 patients with silicosis complicated with cavity-pulmonary tuberculosis (group A) and silicosis patients (group B) admitted to Yantaishan Hospital from July 2018 to July 2022 were collected and analyzed. Results: Patients in group A were all male, and the common symptoms were cough, expectoration, chest tightness, shortness of breath, and hemoptysis. CT cavity lesions involving the lung, often occurs in the lung after the tip section, after the back section and basal segment, thick-walled cavity, may be accompanied by satellite lesions, endobronchial spread focal, pneumothorax, pleural effusion, etc. 1225 cases of group B patients haemoptysis of 59 patients, cavity in 3 patients, haemoptysis and/or cavity rate was lower than that in group A, the difference was statistically significant (P<0.05) . In group A, CT reexamination 6-24 months after anti-tuberculosis treatment showed that 52 cases (82.5%) had cavity reduction/healing, 8 cases (12.7%) had recurrence, and 3 cases (4.8%) had damaged lung (2 died) . Conclusion: Silicosis patients with hemoptysis and/or CT in cavity should be more vigilant about combined tuberculosis, anti-tuberculosis treatment and/or dynamic CT follow-up helps laboratory diagnosis negative patients.


Subject(s)
Silicosis , Tuberculosis, Pulmonary , Humans , Silicosis/complications , Male , Tuberculosis, Pulmonary/complications , Follow-Up Studies , Middle Aged , Tomography, X-Ray Computed , Prognosis , Lung/diagnostic imaging , Lung/pathology , Hemoptysis/etiology , Antitubercular Agents/therapeutic use , Adult
7.
BMJ Case Rep ; 17(3)2024 Mar 27.
Article in English | MEDLINE | ID: mdl-38538102

ABSTRACT

We report the case of a man in his late 30s who presented with a history of breathlessness and cough with haemoptysis. Complete blood counts revealed pancytopenia. High-resolution CT showed diffuse bilateral ground glass opacities. Sequential bronchoalveolar lavage confirmed alveolar haemorrhage. Bone marrow aspiration showed vacuoles in erythroid and myeloid precursor cells. The genome was sequenced, and the UBA1 gene revealed a c.121 A>G mutation (p.Met41Val), confirming vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome. The patient was managed with high-dose prednisolone pulse therapy. He improved with the complete resolution of the alveolar haemorrhage and an improvement in lung function and cytopenias.


Subject(s)
Hemoptysis , Hemorrhage , Myelodysplastic Syndromes , Skin Diseases, Genetic , Male , Humans , Hemorrhage/etiology , Hemoptysis/etiology , Cough , Dyspnea/etiology , Mutation
8.
J Int Med Res ; 52(3): 3000605241237890, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38497130

ABSTRACT

Multi-slice computed tomography (MSCT) is the primary method for the detection and visualization of foreign bodies in the pulmonary artery because it provides high sensitivity and accuracy. It is very difficult to diagnose a patient with a non-iatrogenic pulmonary artery foreign body who does not have a history of a penetrating trauma. This case report describes a 36-year-old male that presented with coughing and haemoptysis. Based on conventional coronal and cross-sectional CT, the foreign body was misdiagnosed as pulmonary tuberculosis and pulmonary artery thrombosis. During treatment of the bronchial artery embolization and anti-tuberculosis therapy, the patient continued to experience haemoptysis. After further analysis of the pulmonary artery CT angiography images and curved multiplane reconstruction, an approximately 6-cm long toothpick was identified in the pulmonary artery with an unclear entry route. After surgery to remove the toothpick, symptoms of coughing and haemoptysis were resolved. This current case demonstrated that multiplane reconstruction in MSCT can improve the detection and visualization of pulmonary artery foreign bodies, which can aid in the diagnosis of pulmonary artery diseases of unknown cause.


Subject(s)
Foreign Bodies , Pulmonary Artery , Adult , Humans , Male , Angiography , Cough , Foreign Bodies/diagnostic imaging , Foreign Bodies/surgery , Foreign Bodies/complications , Hemoptysis/diagnostic imaging , Hemoptysis/etiology , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/surgery , Tomography, X-Ray Computed/methods
9.
Respir Investig ; 62(3): 395-401, 2024 May.
Article in English | MEDLINE | ID: mdl-38484503

ABSTRACT

BACKGROUND: The Guidelines for the Management of Cough and Sputum (2019) of the Japanese Respiratory Society (JRS) were the first internationally published guidelines for the management of sputum. However, the data used to determine the causative diseases of bloody sputum and hemoptysis in these guidelines were not obtained in Japan. METHODS: A retrospective analysis was performed using the clinical information of patients with bloody sputum or hemoptysis who visited the department of respiratory medicine at a university or core hospital in Japan. RESULTS: Included in the study were 556 patients (median age, 73 years; age range, 21-98 years; 302 males (54.3%)). The main causative diseases were bronchiectasis (102 patients (18.3%)), lung cancer (97 patients (17.4%)), and non-tuberculous mycobacterial disease (89 patients (16%)). Sex and age differences were observed in the frequency of causative diseases of bloody sputum and hemoptysis. The most common cause was lung cancer in males (26%), bronchiectasis in females (29%), lung cancer in patients aged <65 years (19%), and bronchiectasis in those aged >65 years (20%). CONCLUSIONS: The present study is the first to investigate the causative diseases of bloody sputum and hemoptysis using data obtained in Japan. When investigating the causative diseases of bloody sputum and hemoptysis, it is important to take the sex and age of the patients into account.


Subject(s)
Bronchiectasis , Lung Neoplasms , Pulmonary Medicine , Male , Female , Humans , Aged , Young Adult , Adult , Middle Aged , Aged, 80 and over , Hemoptysis/epidemiology , Hemoptysis/etiology , Sputum/microbiology , Japan/epidemiology , Hospitals, University , Retrospective Studies , Tomography, X-Ray Computed , Bronchiectasis/epidemiology , Bronchiectasis/complications , Lung Neoplasms/complications , Lung Neoplasms/epidemiology
10.
Tokai J Exp Clin Med ; 49(1): 9-11, 2024 Apr 20.
Article in English | MEDLINE | ID: mdl-38509006

ABSTRACT

We report a case of chronic infection with Pasteurella multocida in the lower respiratory tract in a man with a cat. A 77-year-old man presented with recurrent hemoptysis accompanied by bronchiectasis and an opacity in the left lung on chest computed tomography. Although the patient was seropositive for Mycobacterium avium complex, repeated sputum cultures were negative for any specific pathogen. Three years later, he was referred to our hospital for hemoptysis with enhanced opacity in the lower lobe of the left lung. Culture of bronchial lavage fluid obtained via bronchoscopy was positive for P. multocida. The patient was treated with amoxicillin-clavulanic acid for 14 days and was instructed to avoid close contact with his cat. His symptoms and chest imaging findings improved and have not recurred during more than 1 1/2 years of follow up. P. multocida can cause chronic lower respiratory infections.


Subject(s)
Bronchitis , Pasteurella multocida , Respiratory Tract Infections , Male , Humans , Aged , Hemoptysis/etiology , Respiratory Tract Infections/complications , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/drug therapy , Lung , Bronchitis/diagnosis , Bronchitis/complications
11.
Int J Tuberc Lung Dis ; 28(3): 115-121, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38454184

ABSTRACT

BACKGROUNDPost-TB lung disease (PTLD) can be categorised based on physiological, radiological, and clinical abnormalities, delineating distinct clinical patterns; however, thus far the importance of this is unknown. People with PTLD have a high morbidity and increased mortality, but predictors of long-term outcomes are poorly understood.METHODSWe conducted an observational study of PTLD patients attending a tertiary hospital in South Africa between 1 October 2021 and 30 September 2022. Patient demographics, risk factors, symptoms, lung function tests and outcomes were captured.RESULTSA total of 185 patients were included (mean age: 45.2 years, SD ±14.3). Half of patients reported only one previous episode of Mycobacterium tuberculosis infection (n = 94, 50.8%). There was a statistically significant association between TB-associated obstructive lung disease (OLD) and dyspnoea (P = 0.002), chest pain (P = 0.014) and smoking (P = 0.005). There were significant associations between haemoptysis and both cavitation (P = 0.015) and fungal-associated disease (P < 0.001). Six patients (3.2%) died by study end.CONCLUSIONPTLD can affect young people even with only one previous episode of TB, and carries a high mortality rate. For the first time, clinical patterns have been shown to have meaningful differences; TB-related OLD is associated with dyspnoea, chest pain and smoking; while haemoptysis is associated with cavitary and fungal-associated disease..


Subject(s)
Lung Diseases, Obstructive , Tuberculosis , Humans , Middle Aged , Chest Pain , Dyspnea/etiology , Hemoptysis/etiology , Risk Factors , Tuberculosis/diagnosis , Adult
12.
Am J Case Rep ; 25: e942422, 2024 Mar 13.
Article in English | MEDLINE | ID: mdl-38527273

ABSTRACT

BACKGROUND Hemoptysis due to airway hemorrhage is treated with hemostatic agents, bronchial artery embolization (BAE), or surgical resection. We present the case of a 65-year-old man with refractory hemoptysis associated with chronic progressive pulmonary aspergillosis (CPPA) who failed to respond to combined endobronchial occlusion (EBO) with endobronchial Watanabe spigot (EWS) and BAE. CASE REPORT A 63-year-old man was diagnosed with CPPA in the right upper lung and presented to our hospital 2 years later for hemoptysis at age 65. He developed severe hemoptysis during an outpatient visit, and was urgently admitted, intubated, and ventilated to prevent choking on blood clots. Chest computed tomography showed a large mass in the apical portion of the right lung, constituting apical pleural thickening and an encapsulated pleural effusion, and dilatation in the bronchial artery supplying the right upper lung lobe. Bronchoscopy revealed the right upper lobe B1-B3 as the bleeding source. The patient had recurrent hemoptysis that was not controlled by BAE or 6 EBO+EWS procedures, and he ultimately died of hypoxemia.In the literature review, EBO+EWS can effectively control hemoptysis in appropriate cases, without the need for BAE or surgical lung resection. It is less invasive, is associated with fewer adverse events than BAE or surgery, and can achieve temporary hemostasis for severe hemoptysis. CONCLUSIONS BAE and EBO+EWS were ineffective in controlling recurrent hemoptysis caused by CPPA in this case. However, a multidisciplinary approach such as attempting hemostasis with combined EBO+EWS and BAE may be a viable treatment option in severe cases of hemoptysis.


Subject(s)
Embolization, Therapeutic , Pulmonary Aspergillosis , Vascular Diseases , Aged , Humans , Male , Bronchi , Bronchial Arteries , Embolization, Therapeutic/methods , Hemoptysis/etiology , Hemoptysis/therapy , Pulmonary Aspergillosis/complications , Pulmonary Aspergillosis/therapy , Vascular Diseases/therapy
14.
BMJ Open Respir Res ; 11(1)2024 02 13.
Article in English | MEDLINE | ID: mdl-38350978

ABSTRACT

INTRODUCTION: Haemoptysis can be a feature of lung cancer and patients are typically fast-tracked for evaluation with chest radiography, contrast-enhanced CT and fibreoptic bronchoscopy (FOB). OBJECTIVE: We aim to explore whether FOB should be conducted as a component of the routine evaluation of non-massive haemoptysis, especially in the context of suspected lung cancer. METHODS: MEDLINE, EMBASE and Cochrane Library were searched for studies comparing FOB with CT in the evaluation of non-massive haemoptysis while reporting at least one of the listed primary outcomes. Primary outcomes include sensitivity of diagnostic modality with respect to lung cancer. Secondary outcomes include detection of other aetiologies such as infection. Results were synthesised using a random effects meta-analysis. Sensitivity analysis was performed for patient age group and year of study. Risk of bias assessment was carried out with the Quality Assessment of Diagnostic Accuracy Studies-2 tool. RESULTS: A total of 2273 citations were screened and 11 studies were included, comprising a total sample size of 2015 patients with 226 confirmed cases of lung cancer. A total of 1816 and 1734 patients received a CT scan and FOB, respectively. The pooled sensitivities for detection of lung cancer using CT scan and bronchoscopy were 98% (95% CI 93.0% to 99.0%) and 86% (95% CI 63.0% to 95.0%), respectively. The sensitivity of CT was higher than that of FOB for both primary and secondary outcomes. CONCLUSION: This study suggests that bronchoscopy does not offer significant additional diagnostic benefit in the evaluation of patients presenting with non-massive haemoptysis and a negative CT scan.


Subject(s)
Hemoptysis , Lung Neoplasms , Humans , Hemoptysis/diagnosis , Hemoptysis/etiology , Bronchoscopy/adverse effects , Lung Neoplasms/diagnosis , Lung Neoplasms/diagnostic imaging , Tomography, X-Ray Computed/methods
15.
Chest ; 165(2): e33-e37, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38336441

ABSTRACT

CASE PRESENTATION: A 20-year-old patient with cystic fibrosis (CF) complicated by pansinusitis, pancreatic insufficiency, and diabetes presented to the local ED after an episode of large-volume hemoptysis at home. At baseline, she had advanced lung disease (FEV1, 0.97 L; 31% predicted) and upper lobe-predominant fibrocavitary changes. She was intermittently followed at a regional lung transplant center. She was previously evaluated for transplant but was not listed at the time of this presentation because of nontuberculous mycobacteria infection. She had never used tobacco, without reports of recreational inhaled drug use. Her mother had CF, and one of her brothers died in 2018 at age 24 of respiratory failure resulting from the disease.


Subject(s)
Cystic Fibrosis , Lung Transplantation , Sinusitis , Humans , Male , Female , Young Adult , Adult , Cystic Fibrosis/complications , Cystic Fibrosis/diagnosis , Cystic Fibrosis/microbiology , Hemoptysis/diagnosis , Hemoptysis/etiology , Lung/microbiology
16.
BMJ Case Rep ; 17(2)2024 Feb 29.
Article in English | MEDLINE | ID: mdl-38423568

ABSTRACT

A non-smoker man in his second decade presented to a medical centre with intermittent haemoptysis over 2 years. The haemoptysis was infrequent initially to be ignored, but later, the episodes increased in amount and frequency. Routine blood tests including coagulation profile showed normal results. The chest radiography and echocardiography were normal. The contrast-enhanced CT scan of the chest showed a cystic lesion with intracystic abnormality and surrounding ground-glass opacity in the left upper lobe. The CT pulmonary angiography and invasive pulmonary angiography showed the abnormality to be a dilated pulmonary vessel draining into the left atrium, thereby confirming the diagnosis of congenital pulmonary varix contained within a lung cyst. The patient underwent a successful lobectomy following which he experienced no further haemoptysis.


Subject(s)
Cysts , Lung Diseases , Varicose Veins , Male , Humans , Hemoptysis/etiology , Lung/diagnostic imaging , Lung/surgery , Lung Diseases/diagnostic imaging , Lung Diseases/surgery , Cysts/complications , Cysts/diagnostic imaging , Cysts/surgery , Varicose Veins/congenital
18.
BMJ Case Rep ; 17(1)2024 Jan 03.
Article in English | MEDLINE | ID: mdl-38171635

ABSTRACT

Goodpasture syndrome is a rare autoimmune disease which affects young adults with a male preponderance and can be triggered at any point in life with a classical clinical triad of rapidly progressive glomerulonephritis, diffuse pulmonary haemorrhage and circulating anti-glomerular basement membrane antibody (anti-GBM antibody). Here we are presenting a case of a young man with hypertension in his early 20s who presented with fatigue, recurrent haemoptysis, breathlessness and decreased urine output without features of infection. He was diagnosed at an early stage of the disease with the help of clinical, serological and radiological findings. An early diagnosis with effective treatment using plasma exchange, intravenous high-dose methylprednisolone, and cyclophosphamide showed a rapid improvement in the patient's condition with an immediate decrease in anti-GBM titres and proteinuria.


Subject(s)
Anti-Glomerular Basement Membrane Disease , Young Adult , Male , Humans , Anti-Glomerular Basement Membrane Disease/complications , Anti-Glomerular Basement Membrane Disease/diagnosis , Anti-Glomerular Basement Membrane Disease/therapy , Hemoptysis/etiology , Hemoptysis/drug therapy , Hemorrhage/drug therapy , Cyclophosphamide/therapeutic use , Lung , Autoantibodies
19.
J Cyst Fibros ; 23(1): 165-168, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38184455

ABSTRACT

Bronchial artery embolisation (BAE) is a treatment used to manage haemoptysis. We performed a 7-year review of BAE procedures for haemoptysis at our CF centre aiming to evaluate the incidence and outcomes of patients with neurovascular complications post-BAE. Our review suggests that whilst BAE is an effective method for controlling life-threatening haemoptysis, patients are at risk of developing neurovascular complications with long term residual symptoms, and therefore careful consideration should be given in offering BAE, especially to otherwise well patients with chronic small volume haemoptysis and managing teams should have a low threshold to image symptomatic patients.


Subject(s)
Cystic Fibrosis , Embolization, Therapeutic , Humans , Cystic Fibrosis/complications , Cystic Fibrosis/therapy , Bronchial Arteries , Retrospective Studies , Hemoptysis/diagnosis , Hemoptysis/etiology , Hemoptysis/therapy , Treatment Outcome , Embolization, Therapeutic/adverse effects
20.
Nursing ; 54(2): 44-47, 2024 Feb 01.
Article in English | MEDLINE | ID: mdl-38271131

ABSTRACT

ABSTRACT: Life-threatening hemoptysis (formerly called massive hemoptysis), though relatively uncommon, imposes significant mortality risks. This article discusses the etiology, clinical presentation, assessment, treatment, and nursing interventions to promote effective clinical management of patients with this condition.


Subject(s)
Hemoptysis , Patient Care , Humans , Hemoptysis/etiology , Hemoptysis/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...